HONG KONG DRIVES TRIALS FOR BREAST CANCER, EYE TREATMENTS ACROSS GREATER BAY AREA
REPORT A PROBLEM WITH THIS SOURCE
WHAT HAPPENED
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical… The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater Bay Area International Clinical Trial Institute (GBAICTI) and its…
News - South China Morning Post reports that two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical…
The report adds: The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater Bay Area International Clinical Trial Institute (GBAICTI) and its…
This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.
DAMMNEWS RSS BRIEFING — generated locally from the available News - South China Morning Post headline and RSS excerpt. It is not a summary of the full source article.
RELATED DAMMNEWS COVERAGE
- HONG KONG SHOPPING FESTIVAL EYES ASEAN EXPANSION, WITH SINGAPORE, MALAYSIA FIRST
News - South China Morning Post • 1 hr ago • CHINA - CARS SWEPT AWAY AND TREES TOPPLED AS TYPHOON NOUL BRINGS FLOODING TO SOUTHERN CHINA – VIDEO
China | The Guardian • 1 day ago • CHINA - IRAQ’S NEW PRIME MINISTER IN TURKEY FOR TALKS ON PIPELINE, TRADE AND SECURITY
Associated Press • 30 mins ago • TOP